JF
CATX icon

Jump Financial’s Perspective Therapeutics CATX Stock Holding History

Jump Financial’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$209K Buy
+61,200
New +$231K ﹤0.01% 1833
2025
Q1 		– Sell
-215,725
Closed -$688K – 1618
2024
Q4 		$688K Buy
+215,725
New +$1.76M 0.01% 929

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Jump Financial's CATX Position: Q2 2026 in Review

Jump Financial opened a new position in Perspective Therapeutics (CATX) in Q2 2026: 61,200 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #1833 among its holdings. This is a return to the name: Jump Financial previously reported a position in CATX as recently as Q4 2024.

Jump Financial first reported a position in CATX in Q4 2024 and has held it in 2 quarters since. The position peaked at $688K in Q4 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Jump Financial held 61,200 shares of Perspective Therapeutics worth $209K as of Q2 2026.
  • Perspective Therapeutics was a new Jump Financial position in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1833 holding.
  • Jump Financial first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • Jump Financial's Perspective Therapeutics position peaked at $688K in Q4 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.